Karnataka emerges investors' favourite state; Gujarat left far behind

[email protected] (The Hindu)
August 8, 2016

New Delhi, Aug 8: Gujarat, which was ranked first among all States in 2015 for attracting maximum investment intentions' in value terms, has lost its position to Karnataka halfway through this calendar year.
bio

Gujarat received investment intentions worth only Rs.21,309 crore during January-June 2016, while Karnataka — which topped the list — received over thrice that amount, or Rs.67,757 crore, during the same period, government data showed.

The Centre, which is co-ordinating efforts to rank states on ease of doing business', also maintains a State-wise break-up of investment intentions in terms of Industrial Entrepreneur Memoranda filed for de-licensed sector, Letters of Intent issued and Direct Industrial Licences granted.

Interestingly, the Rs.67,757 crore worth investment intentions received by Karnataka in the first six months of 2016 was more than the Rs.64,733 crore that Gujarat had attracted in the whole of 2015, the year when it topped the all-India list in this regard.

Investors meet

The Rs.64,733 crore-worth investment intentions Gujarat got was 20.81 per cent of the total investment intentions worth Rs.3,11,031 crore that India received in 2015. However, out of the Rs.1,76,738 crore worth proposed investments that India received in January-June 2016, the share of Gujarat declined to 12.06 per cent — or Rs.21,309 crore. Meanwhile, Karnataka's share jumped from 10.18 per cent (or Rs.31,668 crore) in 2015 to 38.34 per cent (or Rs.67,757 crore) in January-June 2016. Karnataka said Invest Karnataka 2016', an investors' meet held during February 3-5 this year, concluded with 1,201 approved projects and MoUs valued at Rs.3.08 lakh crore.

Other leading States in terms of investment intentions' during January-June 2016 were Maharashtra (Rs.15,688 crore), Telengana (Rs.13,600 crore) and Chhattisgarh (Rs.8,514 crore). In 2015, the States in the top five after Gujarat were Chhattisgarh (Rs.36,511 crore), Maharashtra (Rs.33,277 crore), Karnataka (Rs.31,668 crore) and Odisha (Rs.24,524 crore).

Even in the latest Business Reforms Action Plan' index (or measures taken by states to improve ease of doing business), Gujarat was sixth with a score of 53.98 per cent. Uttarakhand topped that dynamic implementation scorecard' with 63.72 per cent, followed by Rajasthan, Telengana, Chhattisgarh and Andhra Pradesh. Gujarat government officials rejected apprehensions that incidents (which even led to changes at the Chief Minister-level) — including the Patidar agitation for reservation and more recently, Dalit protests after some of them were reportedly attacked for allegedly skinning cow carcasses — are leading to lower investor interest in Gujarat.

“These numbers (on investment intentions) keep going up and down. Some big announcements could come up soon and the situation can change,” a senior Gujarat government official said, indicating that some major decisions are likely in the run-up to the Vibrant Gujarat Global Investors' Summit that is slated to be held during January 10-13 next year.

Most of the investment intentions that Gujarat has received are getting converted into amount that is actually being spent on the ground, the official said.

Comments

Abdul Latif
 - 
Monday, 8 Aug 2016

we need development only.....good governence

A.Mangalore
 - 
Monday, 8 Aug 2016

If there is no sangha pariwar goondasm in Mangalore, we would been the top district in terms of development. Now investors are feared to come to our district because of these Rss sponsored terrorists.

Rikaz
 - 
Monday, 8 Aug 2016

Fabulous job CM Siddaramayya....keep going Sir! May God help you....Gujarath was not shining whereas Feku was just cheating....

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 8,2020

Udupi, Apr 8: Six patients were admitted to isolation wards in the hospitals in the district on Tuesday.

While four people were suffering from symptoms of COVID-19, two were suffering from SARI (Severe Acute Respiratory Infection).

As many as 19 samples were collected and sent for Covid-19 testing to a laboratory in Shivamogga.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 16,2020

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”

Comments

kushal kumar
 - 
Thursday, 18 Jun 2020

Trials  of  drug  dexamethasone   in  Covid-19  cases   have  brought  success  in  saving  lives  ,  claim  Oxford  University  scientists  on  16 June  2020. 

              According  to  news  reports  on  16 June  , 2020  ,   Oxford  University  Scientists  have  conducted  trials  on  anti-inflammatory  steroid  Dexamethasone   in  Covid-19  cases.  Results  released  by  the   Oxford  University    on  16  June  2020  say  that  the   low-cost  and  easily  available  drug  saves  the  people  seriously  infected  by   Coronavirus  ,  cuts  the  death  risk  by  a  third  for  those  on  ventilators  and  by  a  fifth  for  those  on  oxygen.  The  commentary   on  the  drug   reads  like  this  :-

“  This  is  a  tremendous  news  today  from  the  recovery  trial  showing  that  dexamethasone   is  the  first  drug  to  reduce  mortality  from  Covid-19.  It  is  particularly  exciting  as  this  is  an  inexpensive  widely  available  medicine.  This  is  a  ground  breaking  development  in  our  fight  against  the  disease  and  the  speed  at  which  researchers  have  progressed  finding  an  effective  treatment  ,  is  truly  remarkable.  It  shows  importance  of  doing  high  quality  clinical  trials  and  basing  decisions  as  the  results  of  those  trials”. 

               Covid-19  has  taken  into  its  grip   the  entire  world  during  first  half  of  the  year  2020  ,  infecting   lacs  and  killing  also  lacs  of   its  patients.  In  the  absence  of  an  effective  drug  or  vaccine  ,  people  had  no  choice  other  than   to   look   up   to  the  heavens  or   scientists  to  come  with  some  cure.  And  the  drug  described  here  is  the  first  one  to  respond  to  the  prayer   of  the  global  community  ,  it  seems.     As  regards  a  vaccine  ,   only  few  are  claiming  that  it  can  come  by  the  end  of  the  present  year  2020.  Rather   ,  some  are  of  the  view  that  it  may  take  a  larger  part  of  the  year  2021  and   could   even  go    to  mid-2022.   Whatever  that  scenario  about  prospect  of  arrival  of  vaccine  to  treat  Covid-19  may  be   ,  the  news  that  was  broken   on  16  June  2020   by   the  Oxford  University   scientists   in  relation  to   drug  dexamethasone   would  have  sent  a  wave  of   strength  and  hope   among   people  world-wide.  And  this  Vedic  astrology  writer  was  spirited  for  another  reason  as   well   -  a  prediction  of   when  some  relief   by  way  of  drug  to  fight  Covid-19   may  appear  ,   having  come  accurate  in   the   claim  announced  by  Oxford  University   on  16 June  2020.  This  writer  had  ,   based   on  interpretation  and  application   of  Vedic  astrology  ,   contributed  in  early  April  ,  2020   an  opinion  piece     - “  Some  searchlight  on  way  out  of  Covid-19  presently  tormenting  mankind” -   to  a  number  of   newspapers.  It  was  also  contributed  on  11  April  ,  2020   using  the  ‘ comments’   column  of  article  -‘ Heard  Charles  took   Ayurveda  treatment-based  Ayush  drugs  for   Covid-19’  -   at   theprint.in/india/looking-at-evidence-based-ayush-medicines-to-treat-covid-19-minister-shripad-naik/393407/.   The  text  in  the  opinion  piece  related  to  the  claim  of  success  announced  by  Oxford  University  scientists  on  16 June  ,  2020  ,  reads  like  this  :- 

“  So  reading  in  between  the  lines  ,  it  can  be  said  that  some  effective  drug   or  remedy  can  arrive  by   mid   or  towards   the  last  week  of  June  2020   to   provide  some  relief  during  July  to  September  2020 ,  to  some  good  extent”.

The  point  this  writer  wants  to  share  with  readers  world-wide  is  that   yes  ,  a  drug   envisaged  in  the  aforesaid  prediction  has  appeared  on  the  horizon  in  the  claim  announcement  of  Oxord  University  scientists  on  16  June ,  2020. 

Bio  :-

 

Kushal  kumar  ,

202-GH28  ,  Mansarovar   Apartments  ,

Sector  20  ,  Panchkula-134116  ,  Haryana,

India.

Note  :-  This  writer’s    significant  predictive  work  covering   2020   about   the  U.S.  and  Italy

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 20,2020

Karanataka, Apr 20: Chief Minister of Karnataka BS Yediyurappa launched an online crash course programme 'GetCETGo', here on Monday.

GetCETGo is the state government's free online crash course programme to help all students of Karnataka prepare for Common Entrance Test (CET) and National Eligibility-cum-Entrance Test (NEET).

The programme was launched by the state government amid the disruption in education sector caused due to the nationwide COVID-19 lockdown.

Students can access the content through the web portal and the Android Application that has been developed by Sinchu Infotech and Deeksha Online.

They can also avail comprehensive study material with practice questions, chapter-wise tests, revision videos and mock tests.

According to the state government, this programme will benefit around 1,94,000 students.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.